Immunotherapy in biliary tract cancers: current standard-of-care and emerging strategies
JH Lo, R Agarwal, LW Goff, TR Heumann - Cancers, 2023 - mdpi.com
Simple Summary Biliary tract cancers (BTCs), comprising cancers of the bile ducts
(cholangiocarcinoma) as well as gallbladder cancers, continue to be challenging to treat …
(cholangiocarcinoma) as well as gallbladder cancers, continue to be challenging to treat …
An immune score reflecting pro-and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid …
A Mezheyeuski, M Backman, J Mattsson… - …, 2023 - thelancet.com
Background Cancer immunity is based on the interaction of a multitude of cells in the spatial
context of the tumour tissue. Clinically relevant immune signatures are therefore anticipated …
context of the tumour tissue. Clinically relevant immune signatures are therefore anticipated …
TIMP1 is an early biomarker for detection and prognosis of lung cancer
E Dantas, A Murthy, T Ahmed, M Ahmed… - Clinical and …, 2023 - Wiley Online Library
Background Lung cancer remains the major cause of cancer‐related deaths worldwide.
Early stages of lung cancer are characterized by long asymptomatic periods that are …
Early stages of lung cancer are characterized by long asymptomatic periods that are …
FAP-retargeted Ad5 enables in vivo gene delivery to stromal cells in the tumor microenvironment
KP Hartmann, M van Gogh, PC Freitag, F Kast… - Molecular Therapy, 2023 - cell.com
Fibroblast activation protein (FAP) is a cell surface serine protease that is highly expressed
on reactive stromal fibroblasts, such as cancer-associated fibroblasts (CAFs), and generally …
on reactive stromal fibroblasts, such as cancer-associated fibroblasts (CAFs), and generally …
[HTML][HTML] Deciphering the morphology of tumor-stromal features in invasive breast cancer using artificial intelligence
Tumor-associated stroma in breast cancer (BC) is complex and exhibits a high degree of
heterogeneity. To date, no standardized assessment method has been established. Artificial …
heterogeneity. To date, no standardized assessment method has been established. Artificial …
Overexpression and role of HHLA2, a novel immune checkpoint, in colorectal cancer
A Kula, M Dawidowicz, S Mielcarska, P Kiczmer… - International Journal of …, 2023 - mdpi.com
The study aimed to investigate correlations between HHLA2 levels and parameters,
including microsatellite instability (MSI) status, CD8+ cells, and histopathological features …
including microsatellite instability (MSI) status, CD8+ cells, and histopathological features …
Tumor Stroma Area and Other Prognostic Factors in Pancreatic Ductal Adenocarcinoma Patients Submitted to Surgery
MJ Amaral, M Amaral, J Freitas, RC Oliveira, M Serôdio… - Diagnostics, 2023 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) has a dense stroma, responsible for up to 80%
of its volume. The amount of stroma can be associated with prognosis, although there are …
of its volume. The amount of stroma can be associated with prognosis, although there are …
Clinical Significance of the Stromatic Component in Ovarian Cancer: Quantity Over Quality in Outcome Prediction
Background The tumor stroma is composed of a complex network of non-cancerous cells
and extracellular matrix elements that collectively are crucial for cancer progression and …
and extracellular matrix elements that collectively are crucial for cancer progression and …